Impax Asset Management Group plc Boosts Holdings in Mettler-Toledo International Inc. (NYSE:MTD)

Impax Asset Management Group plc grew its stake in shares of Mettler-Toledo International Inc. (NYSE:MTD - Free Report) by 6.6% in the fourth quarter, according to its most recent disclosure with the SEC. The fund owned 192,857 shares of the medical instruments supplier's stock after buying an additional 11,880 shares during the period. Impax Asset Management Group plc owned approximately 0.89% of Mettler-Toledo International worth $233,928,000 as of its most recent filing with the SEC.

Other large investors have also made changes to their positions in the company. Cambridge Investment Research Advisors Inc. increased its stake in Mettler-Toledo International by 8.0% in the first quarter. Cambridge Investment Research Advisors Inc. now owns 176 shares of the medical instruments supplier's stock valued at $242,000 after acquiring an additional 13 shares during the period. Raymond James Trust N.A. grew its stake in Mettler-Toledo International by 19.7% during the first quarter. Raymond James Trust N.A. now owns 176 shares of the medical instruments supplier's stock worth $242,000 after buying an additional 29 shares during the last quarter. Vontobel Holding Ltd. grew its stake in shares of Mettler-Toledo International by 48.9% during the first quarter. Vontobel Holding Ltd. now owns 834 shares of the medical instruments supplier's stock valued at $1,172,000 after purchasing an additional 274 shares during the last quarter. Sei Investments Co. grew its stake in shares of Mettler-Toledo International by 4.2% during the first quarter. Sei Investments Co. now owns 16,305 shares of the medical instruments supplier's stock valued at $21,817,000 after purchasing an additional 662 shares during the last quarter. Finally, Prudential PLC bought a new stake in shares of Mettler-Toledo International during the first quarter valued at approximately $626,000. Institutional investors and hedge funds own 95.07% of the company's stock.

Insider Transactions at Mettler-Toledo International

In related news, Director Elisha W. Finney sold 251 shares of the firm's stock in a transaction on Monday, February 12th. The shares were sold at an average price of $1,177.35, for a total value of $295,514.85. Following the completion of the transaction, the director now owns 316 shares of the company's stock, valued at $372,042.60. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. In related news, Director Elisha W. Finney sold 251 shares of the firm's stock in a transaction on Monday, February 12th. The shares were sold at an average price of $1,177.35, for a total value of $295,514.85. Following the completion of the transaction, the director now owns 316 shares of the company's stock, valued at $372,042.60. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, insider Christian Magloth sold 400 shares of the firm's stock in a transaction on Monday, March 4th. The shares were sold at an average price of $1,278.73, for a total transaction of $511,492.00. Following the completion of the transaction, the insider now directly owns 734 shares of the company's stock, valued at approximately $938,587.82. The disclosure for this sale can be found here. Insiders sold 951 shares of company stock valued at $1,170,256 over the last quarter. Corporate insiders own 1.94% of the company's stock.

Analyst Upgrades and Downgrades

MTD has been the topic of several research analyst reports. Citigroup reissued a "sell" rating and set a $975.00 price target (down from $1,050.00) on shares of Mettler-Toledo International in a research note on Monday, December 11th. Evercore ISI increased their price objective on shares of Mettler-Toledo International from $1,200.00 to $1,300.00 and gave the company an "in-line" rating in a report on Thursday, April 4th. Finally, StockNews.com upgraded shares of Mettler-Toledo International from a "hold" rating to a "buy" rating in a report on Sunday, March 31st. One research analyst has rated the stock with a sell rating, three have issued a hold rating and three have given a buy rating to the company. According to MarketBeat.com, Mettler-Toledo International currently has a consensus rating of "Hold" and an average target price of $1,233.25.

Mettler-Toledo International Price Performance

MTD traded up $32.33 during mid-day trading on Tuesday, hitting $1,336.60. The stock had a trading volume of 90,272 shares, compared to its average volume of 144,480. The stock's fifty day simple moving average is $1,263.88 and its 200-day simple moving average is $1,164.20. The firm has a market capitalization of $28.59 billion, a price-to-earnings ratio of 37.24, a price-to-earnings-growth ratio of 3.55 and a beta of 1.15. Mettler-Toledo International Inc. has a 1-year low of $928.49 and a 1-year high of $1,615.97.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last issued its quarterly earnings data on Friday, February 9th. The medical instruments supplier reported $9.40 earnings per share (EPS) for the quarter, missing the consensus estimate of $10.32 by ($0.92). Mettler-Toledo International had a negative return on equity of 904.59% and a net margin of 20.82%. The company had revenue of $934.90 million for the quarter, compared to the consensus estimate of $959.45 million. During the same period in the prior year, the company earned $12.10 EPS. The firm's revenue was down 11.6% on a year-over-year basis. As a group, research analysts expect that Mettler-Toledo International Inc. will post 39.9 earnings per share for the current fiscal year.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.